Apollo Care, LLC

FDA recalling firm · 3 enforcement events · 28 product records · 2023–2026 · MO

Apollo Care, LLC has 3 FDA enforcement events on this register (28 product records) between 2023 and 2026: 3 drug; the busiest year was 2023 with 1.

0% of its events are Class I; the most common class is Class II (3). 3 events are listed as ongoing; the recalling firm's address is in MO.

Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.

Enforcement events

Initiated	Product (first record)	Type	Class	Records	Status
29 Jul 2026	SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05	Drug	Class II	11	Ongoing
15 Apr 2025	FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% Sodium Chloride Injection (For Epidural Use Only), Sterile, Single-Use Container, Rx Only, Apollocare, 3801 Mojave Ct, Ste 101, Columbia, MO 65202, NDC 71170-950-25	Drug	Class II	1	Ongoing
2 May 2023	PHENYLephrine HCl Injection, 1 mg per 10 mL (100 mcg/mL), Single-Use Syringe, Solution for IV Use Only. Apollo Care, LLC, 3801 Mojae Ct., Suite 101, Columbia, MO 65202. NDC: 71170-010-10	Drug	Class II	16	Ongoing

By type and class

Drug3

Class II3

Class I: 0% of this firm's events; 18% of all events on the register.

Events by year

Enforcement events for Apollo Care, LLC by year initiated.

Questions and answers

How many FDA recalls has Apollo Care, LLC had?

3 enforcement events (28 product records) on this register, 2023–2026: 3 drug.

Are any Apollo Care, LLC recalls ongoing?

3 events are listed as ongoing in the current openFDA export.

What class are Apollo Care, LLC recalls?

3 Class II. 0% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.

Where does this data come from?

openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.

Provenance

Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.